Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.02M Sell
14,021
-55,793
-80% -$6.83M 0.09% 156
2025
Q2
$7.03M Buy
+69,814
New +$5.34M 0.46% 52
2022
Q4
Sell
-3,856
Closed -$83K 843
2022
Q3
$83K Buy
3,856
+1,146
+42% +$27.5K ﹤0.01% 1287
2022
Q2
$53K Sell
2,710
-3,467
-56% -$72.6K ﹤0.01% 1364
2022
Q1
$145K Buy
6,177
+4,508
+270% +$105K 0.01% 1054
2021
Q4
$45K Buy
+1,669
New +$47.7K ﹤0.01% 1371
2021
Q3
Sell
-2,926
Closed -$83K 2208
2021
Q2
$83K Buy
2,926
+2,208
+308% +$65.5K ﹤0.01% 1359
2021
Q1
$24K Sell
718
-34
-5% -$1.3K ﹤0.01% 1438
2020
Q4
$25K Buy
+752
New +$27.5K ﹤0.01% 1375
2020
Q3
Sell
-3,242
Closed -$89K 1345
2020
Q2
$89K Buy
+3,242
New +$76.9K 0.01% 652
2019
Q4
Sell
-1,514
Closed -$27K 1286
2019
Q3
$27K Buy
1,514
+203
+15% +$3.92K 0.01% 667
2019
Q2
$34K Buy
+1,311
New +$36.5K 0.01% 686
2018
Q4
Sell
-288
Closed -$6K 1038
2018
Q3
$6K Buy
+288
New +$6.5K ﹤0.01% 694

Other funds holding INSM

Point72 Hong Kong's INSM Position: Q3 2025 in Review

Point72 Hong Kong reduced its Insmed (INSM) stake by 80% in Q3 2025, selling an estimated $6.83M and leaving 14,021 shares worth $2.02M. The position accounts for 0.09% of the portfolio, ranked #156.

Point72 Hong Kong first reported a position in INSM in Q3 2018 and has held it in 13 quarters since. The position peaked at $7.03M in Q2 2025. 566 funds tracked by Wall St. Rank hold INSM as of Q3 2025.

  • Point72 Hong Kong held 14,021 shares of Insmed worth $2.02M as of Q3 2025.
  • Point72 Hong Kong sold 55,793 Insmed shares in Q3 2025, an estimated $6.83M.
  • Insmed made up 0.09% of Point72 Hong Kong's portfolio in Q3 2025, its #156 holding.
  • Point72 Hong Kong first reported a position in Insmed in Q3 2018 and has held it in 13 quarters since.
  • Point72 Hong Kong's Insmed position peaked at $7.03M in Q2 2025.
  • 566 funds tracked by Wall St. Rank held Insmed as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.